Chemotherapy with the "8 in 1" protocol for malignant brain tumors in children: A population-based study in Finland

Pediatric Hematology and Oncology

Volumn 13, Issue 1, 1996, Pages 69-80

  Ilveskoski, Ismo ^a   Saarinen, Ulla M ^a   Perkkiö, Mikko ^b   Salmi, Toivo T ^c   Lanning, Mariatta ^d   Mäkipernaa, Anne ^e   Sankila, Risto ^f   Pihko, Helena ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f FINNISH CANCER REGISTRY   (Finland)

Author keywords

"8 in 1" chemotherapy; Glioma; Malignant brain tumor; Medulloblastoma; Primitive neuroectodermal tumor

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; HYDROXYUREA; LOMUSTINE; MANNITOL; METHYLPREDNISOLONE; PREDNISONE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ARTICLE; BRAIN CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL PROTOCOL; CONTROLLED STUDY; DOSE CALCULATION; EPENDYMOMA; FEMALE; FEVER; GLIOBLASTOMA; GLIOMA; HUMAN; INFANT; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; NEUROECTODERM TUMOR; NEUTROPENIA;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FINLAND; GLIOMA; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; SURVIVAL RATE;

EID: 0030044738     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.3109/08880019609033373     Document Type: Article

References (22)

1. Duffner P, Cohen M, Myers M, Heise H. Survival of children with brain tumors. SEER Program, 1973-1980. Neurology. 1986;36:597-601.
2. Lannering B, Marky I, Nordborg C. Brain tumors in childhood and adolescence In West Sweden 1970-84: epidemiology and survival. Cancer. 1990;66:604-609.
3. Evans E, Jenkin D, Sposto R, et al. The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg. 1990;92:572-582.
4. Sposto R, Ertel I, Jenkin R, et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. J Neurooncol. 1989;7:165-177.
5. Krischer J, Ragab A, Kun L, et al. Nitrogen mustard, vincristine, procarbazine and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg. 1991;74:905-909.
6. Goldie J. New thoughts on resistance to chemotherapy. Hosp Pract. 1983;18:165-177.
7. Chabner B. The evolution of cancer chemotherapy. Hosp Pract. 1985;20:115-127.
8. Hill B, Baserga R. The cell cycle and its significance for cancer treatment. Cancer Treat Rev. 1975;2:159-175.
9. Price L, Hill B. Safe and effective induction chemotherapy without cisplatin for squamous carcinoma of the head and neck. Med Pediatr Oncol. 1982;10:535-548.
10. Bleyer A, Millstein J, Balis F, Pendergrass T, Chard R, Hartmann J. Eight drugs in 1 day chemotherapy for brain tumors: a new approach and rationale for preradiation chemotherapy. Med Pediatr Oncol. 1983;11:213.
11. Edwards M, Levin V, Wilson C. Brain tumor chemotherapy: an evaluation of agents in current use for phase II and III trials. Cancer Treat Rep. 1980;64:1179-1205.
12. Pendergrass T, Milstein J, Geyer R, et al. Eight drugs in one day chemotherapy for brain tumors: experience in 107 children and rationale for preradiation chemotherapy. J Clin Oncol. 1987;8:1221-1231.
13. Kernohan J, Mabon R, Swien J, et al. A simplified classification of gliomas. Mayo Clin Proc. 1949;24:71-75.
14. Rorke L, Gilles F, Davis R, Becker L. Revision of the World Health Organization classification of brain tumors for childhood brain tumors. Cancer. 1985;56:1869-1886.
15. Packer R, Sutton L, Goldwein J, et al. Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastoma. J Neurosurg. 1991;74:433-440.
16. Chang C, Housepian E, Herpert CJ. An operative staging system and a megavoltage radiotherapy technique for cerebellar medulloblastomas. Radiology. 1969;93:1351-1359.
17. Cutler S, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis. 1958;8:699-712.
18. Hakulinen T, Tenkanen L, Abeywickrama K, Päivärinta L. Testing equality of relative survival patterns based on aggregated data. Biometrics. 1987;43:313-325.
19. Clausen N, Garwics S, Glomstein A, Jonmundsson G, Kruus S, Yssing M. Medulloblastoma in Nordic children: incidence and mortality. Acta Paediatr Scand Suppl 1990;371:5-11.
20. Bouffet E, Gentet JC, Doz F, et al. Metastatic medulloblastoma: the experience of the French cooperative M7 group. Eur J Cancer. 1994;30A:1478-1483.
21. Packer RJ, Sutton LN, Elterman R, et al. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy. J Neurosurg. 1994;81:690-698.
22. Ross G, Rubinstein L. Lack of histopathological correlation of malignant ependymomas with postoperative survival. J Neurosurg. 1989;70:31-36.